CNTX
Context Therapeutics Inc
NASDAQ: CNTX · HEALTHCARE · BIOTECHNOLOGY
$2.34
-6.77% today
Updated 2026-04-29
Market cap
$207.65M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$0 – $4
Volume
0.9M
Context Therapeutics Inc (CNTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-46.40%
ROA
-29.80%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-37.67M | — | — | — |
| 2017 | $0.00 | $-24.61M | — | — | — |
| 2019 | $0.00 | $-7.48M | — | — | — |
| 2020 | $0.00 | $6.64M | — | — | — |
| 2021 | $0.00 | $-10.46M | — | — | — |
| 2022 | $0.00 | $-14.84M | — | — | — |
| 2023 | $0.00 | $-23.96M | — | — | — |
| 2024 | $0.00 | $-26.73M | — | — | — |
| 2025 | $0.00 | $-36.12M | — | — | — |